Paracel Explorer

Dernière publication·Juillet 2026

Juluca

Dolutegravirum / Rilpivirinum — cpr pell 50/25 mg

ViiV Healthcare GmbH

Swissmedic66790

Dossier20814

Remboursement

QP 10%

Modifications (4)